Title of Collaborative Activity: |
FDA Memorandum of Understanding with NHLBI [Docket No. FDA–2008–N–0043] |
Description of Collaborative Activity: |
The group meets quarterly at alternate sites to discuss stem cell research, cell therapy research, and clinical trials related to these areas. Group members are invited to and attend CBER or NHLBI working groups and workshops on these topics. |
Type of Collaborative Activity: |
Committee, Advisory Group, or Work Group
|
Year the Collaborative Activity Originated: |
2008 |
NIH Participating Institutes/Centers/Office of the Director: |
NHLBI |
HHS Agency Collaborators on this Activity: |
FDA |
